130 related articles for article (PubMed ID: 18496864)
1. Carbonate substituted hydroxyapatite: resorption by osteoclasts modifies the osteoblastic response.
Spence G; Patel N; Brooks R; Rushton N
J Biomed Mater Res A; 2009 Jul; 90(1):217-24. PubMed ID: 18496864
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastogenesis on hydroxyapatite ceramics: the effect of carbonate substitution.
Spence G; Patel N; Brooks R; Bonfield W; Rushton N
J Biomed Mater Res A; 2010 Mar; 92(4):1292-300. PubMed ID: 19343778
[TBL] [Abstract][Full Text] [Related]
3. Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate: the importance of bioresorption to osteoconduction.
Spence G; Phillips S; Campion C; Brooks R; Rushton N
J Bone Joint Surg Br; 2008 Dec; 90(12):1635-40. PubMed ID: 19043138
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast and osteoclast responses to A/B type carbonate-substituted hydroxyapatite ceramics for bone regeneration.
Germaini MM; Detsch R; Grünewald A; Magnaudeix A; Lalloue F; Boccaccini AR; Champion E
Biomed Mater; 2017 Jun; 12(3):035008. PubMed ID: 28351999
[TBL] [Abstract][Full Text] [Related]
5. Biological responses of human osteoblasts and osteoclasts to flame-sprayed coatings of hydroxyapatite and fluorapatite blends.
Bhadang KA; Holding CA; Thissen H; McLean KM; Forsythe JS; Haynes DR
Acta Biomater; 2010 Apr; 6(4):1575-83. PubMed ID: 19857609
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite.
Botelho CM; Brooks RA; Spence G; McFarlane I; Lopes MA; Best SM; Santos JD; Rushton N; Bonfield W
J Biomed Mater Res A; 2006 Sep; 78(4):709-20. PubMed ID: 16739170
[TBL] [Abstract][Full Text] [Related]
7. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts.
Dempster DW; Hughes-Begos CE; Plavetic-Chee K; Brandao-Burch A; Cosman F; Nieves J; Neubort S; Lu SS; Iida-Klein A; Arnett T; Lindsay R
J Cell Biochem; 2005 May; 95(1):139-48. PubMed ID: 15723294
[TBL] [Abstract][Full Text] [Related]
8. In vitro osteoclast formation and resorption of silicon-substituted hydroxyapatite ceramics.
Friederichs RJ; Brooks RA; Ueda M; Best SM
J Biomed Mater Res A; 2015 Oct; 103(10):3312-22. PubMed ID: 25847383
[TBL] [Abstract][Full Text] [Related]
9. Mechanical regulation of osteoclastic genes in human osteoblasts.
Kreja L; Liedert A; Hasni S; Claes L; Ignatius A
Biochem Biophys Res Commun; 2008 Apr; 368(3):582-7. PubMed ID: 18243138
[TBL] [Abstract][Full Text] [Related]
10. Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics.
Xue W; Moore JL; Hosick HL; Bose S; Bandyopadhyay A; Lu WW; Cheung KM; Luk KD
J Biomed Mater Res A; 2006 Dec; 79(4):804-14. PubMed ID: 16886220
[TBL] [Abstract][Full Text] [Related]
11. Formation of osteoclast-like cells on HA and TCP ceramics.
Detsch R; Mayr H; Ziegler G
Acta Biomater; 2008 Jan; 4(1):139-48. PubMed ID: 17723325
[TBL] [Abstract][Full Text] [Related]
12. Biological response of human bone cells to zinc-modified Ca-Si-based ceramics.
Ramaswamy Y; Wu C; Zhou H; Zreiqat H
Acta Biomater; 2008 Sep; 4(5):1487-97. PubMed ID: 18501689
[TBL] [Abstract][Full Text] [Related]
13. The response of osteoblasts to nanocrystalline silicon-substituted hydroxyapatite thin films.
Thian ES; Huang J; Best SM; Barber ZH; Brooks RA; Rushton N; Bonfield W
Biomaterials; 2006 May; 27(13):2692-8. PubMed ID: 16423389
[TBL] [Abstract][Full Text] [Related]
14. Electrophoretic deposition of hydroxyapatite coating on Fecralloy and analysis of human osteoblastic cellular response.
Guo X; Gough J; Xiao P
J Biomed Mater Res A; 2007 Jan; 80(1):24-33. PubMed ID: 16958045
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastic cell response on fluoridated hydroxyapatite coatings.
Wang Y; Zhang S; Zeng X; Ma LL; Weng W; Yan W; Qian M
Acta Biomater; 2007 Mar; 3(2):191-7. PubMed ID: 17142117
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles.
Vallés G; Gil-Garay E; Munuera L; Vilaboa N
Biomaterials; 2008 May; 29(15):2326-35. PubMed ID: 18313744
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells.
Capuccini C; Torricelli P; Boanini E; Gazzano M; Giardino R; Bigi A
J Biomed Mater Res A; 2009 Jun; 89(3):594-600. PubMed ID: 18437694
[TBL] [Abstract][Full Text] [Related]
18. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces.
Schuessele A; Mayr H; Tessmar J; Goepferich A
J Biomed Mater Res A; 2009 Sep; 90(4):959-71. PubMed ID: 18655137
[TBL] [Abstract][Full Text] [Related]
19. Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts in vitro.
Balani K; Anderson R; Laha T; Andara M; Tercero J; Crumpler E; Agarwal A
Biomaterials; 2007 Feb; 28(4):618-24. PubMed ID: 17007921
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast response to nanocrystalline calcium hydroxyapatite depends on carbonate content.
Adams BR; Mostafa A; Schwartz Z; Boyan BD
J Biomed Mater Res A; 2014 Sep; 102(9):3237-42. PubMed ID: 24167147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
